How do you rapidly but safely move new candidates through the clinic?
Experts from the cell and gene therapy field share their experiences and discuss trends to accelerate therapies from the bench to the bedside. This webinar focuses on strategies for start-ups, specifically the industrialization of cell and gene therapies, how to look at robust scale-up, and reducing new CMC risk.
J. Kelly Ganjei, CEO of Cognate BioServices
David Pryce, CEO of Devacel
Shailesh Maingi,Founder and Chairman of Kineticos Life Sciences
Moderated by: Beth Webb, Global GM for Commercial for Cell and Gene Therapy at Cytiva